The startup has enlisted scientists and researchers in the field of longevity to produce a supplement line to optimise long-term health as well as slow and even reverse some of the signs of aging

An ever-increasing number of consumers are not only looking at supplements to boost health and vitamin levels but have started to actively invest in a longer healthy lifespan. Aimed to capture this growing market, Swiss-based longevity supplement startup Avea has raised €2.43 million in funding.

The startup is on a mission to extend human health span with science-based supplements. It has enlisted scientists and researchers in the field of longevity to produce a supplement line to optimise long-term health as well as slow and even reverse some of the signs of aging. The startup plans to use the funding for expansion across Switzerland, Germany, Austria and the U.K.

More read here: https://tech.eu/2022/06/03/swiss-longevity-startup-avea-gets-eur243-million-booster